Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exchange Transfusion vs Convalescent Plasma + Methylene Blue in COVID-19
NCT04376788Phase 2Unknown
- Sponsor
- Ain Shams University
- Start
- May 2020
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of methylene blue and convalescent plasma (Heinrich-Heine University, Duesseldorf) in coronavirus disease 2019 (COVID-19) (3 arms), sponsored by Ain Shams University. Primary endpoint: Improvement of condition. Status: unknown.
02
Drugs
methylene blueconvalescent plasma (Heinrich-Heine University, Duesseldorf)
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04376788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04376788.